Global Bioenergies has completed a stage of significant expansion with the completion of its Leuna demo plant and a raft of industrial agreements in 2016. 2016 results reflected this expansion in line with our expectations and the company closed the year having comfortably funded its cash spend for 2017. It now needs to deliver commercial revenues to reach profitability. We have updated our forecasts to reflect a more conservative revenue expectation and the Syngip acquisition. Our valuation
03 May 2017
Towards scale and revenues
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Towards scale and revenues
Global Bioenergies SA (ALGBE:PAR) | 0 0 1.6% | Mkt Cap: 77.3m
- Published:
03 May 2017 -
Author:
Catharina Hillenbrand-Saponar -
Pages:
4
Global Bioenergies has completed a stage of significant expansion with the completion of its Leuna demo plant and a raft of industrial agreements in 2016. 2016 results reflected this expansion in line with our expectations and the company closed the year having comfortably funded its cash spend for 2017. It now needs to deliver commercial revenues to reach profitability. We have updated our forecasts to reflect a more conservative revenue expectation and the Syngip acquisition. Our valuation